People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Revelation Biosciences, Inc | — | Biotechnology | Series A | $10.5M | $119.0M | 2021 |
Chester S. Zygmont III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chester S. Zygmont III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| George F. Tidmarsh | 1 | 2 |
| Jennifer F. Carver | 1 | 1 |
| Jess F. Roper | 1 | 1 |
| James M. Rolke | 1 | 1 |
| Curt F. LaBelle | 1 | 1 |
| Chester S. Zygmont | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.